| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
1149 |
| issn |
1387-2877
1875-8908 |
| issueIdentifier |
4 |
| pageRange |
1079-1149 |
| publicationName |
Journal of Alzheimer's disease : JAD |
| startingPage |
1079 |
| bibliographicCitation |
Froestl W, Pfeifer A, Muhs A. Cognitive enhancers (Nootropics). Part 3: drugs interacting with targets other than receptors or enzymes. Disease-modifying drugs. Update 2014. J Alzheimers Dis. 2014;42(4):1079–149. doi: 10.3233/jad-141206. PMID: 25061058. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d13709d1e88dc741f5e2aabd2dd5205
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f34c41cc98e44b2a5d9147c0bd314656
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_960d396af8a4222c4c812c8105f2060e |
| date |
2014-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.3233/jad-141206
https://pubmed.ncbi.nlm.nih.gov/25061058 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
https://portal.issn.org/resource/ISSN/1875-8908
https://portal.issn.org/resource/ISSN/1387-2877 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Cognitive Enhancers (Nootropics). Part 3: Drugs Interacting with Targets other than Receptors or Enzymes. Disease-Modifying Drugs. Update 2014 |
| discusses |
http://id.nlm.nih.gov/mesh/M0028009 |